Two years ago, we demonstrated that the SARS-CoV-2 pandemic likely began at the Huanan Market via zoonosis resulting from the wildlife trade. Many unanswered questions remained about the animals themselves. Some answers, out today in Cell. cell.com/cell/fulltext/…

In this Episode, Dr Hitasha Rupani talks about her role working in asthma, some of the challenges currently facing patients with asthma and where she hopes the future of #asthma care will head, including the use of #biologics. Listen here: tinyurl.com/29xmyeh2 #HealthPodcast

Biggest medical discoveries of the week (🧵) 1/8 Single dose CRISPR for hereditary angioedema, a genetic condition that causes unpredictable swelling attacks This phase 2, placebo-controlled randomised trial found that CRISPR editing of kallikrein (KLKB1) reduced angioedema

Happy Halloween Mark Toshner

Physical activity is safer and more effective than drugs for chronic pain. Here we identify the barriers and facilitators to its uptake. Callum Leese UoD Medicine NRS Pain Research Community Lesley Colvin Prof. Paul Cameron Harry L. Hébert Chronic Pain Research Group Dundee University journals.lww.com/pain/abstract/…

🎉 Huge congratulations to Professors Blair H Smith & Albena Dinkova-Kostova from University of Dundee School of Medicine for being named among the world's most cited researchers! 🌍📚 Their work is making a global impact. 👏

The calm before the storm. Or the inhalation before the cough? It’s #BTSWinterMeeting2024

Very hopeful of spotting Mark Toshner's Waistcoat at BTS this year.

Good to be at #btswinter2024 today! This afternoon, I'm presenting this poster on prevalence and motivations behind purchasing inhalers online.

Churchill room well stocked for the first session of #btswinter2024 with Guy Brusselle exploring the Type 2 inflammation in COPD. Eosinophils can be markers, or makers in airways disease.

Guy Brussels: "Just because a COPD patient is admitted doesn't make it a severe exacerbation" Preach, brother Guy! Phenotyping exacerbations has to be part of routine care in airways disease. *Type* of exacerbation, not frequency or 'severity' #btswinter2024

This year’s #BTSWinter2024 opening with a bang 💥 A revolution in #COPD - are we there…? Fabulous overview from Guy Brusselle Surya P Bhatt, MD, MSPH & Mona Bafadhel on biologics - where we are and where we might be going 🧐 Great start to a great Meeting! #respisbest 🫁

#BTSWinter2024 Incredible overview from Mahdi Sheikh on the substantial benefits from treating tobacco dependency at the time of cancer diagnosis - simple, cheap & highly cost-effective interventions. Must be an urgent priority for all cancer teams to implement comprehensively

NRAP data deep-dives at #BTSWinter2024. Apologies for the crap photo - but only 23% patients with COPD exacerbations (presumably) admitted to a resp ward? And less than half seen by a resp specialist post-take? Eye-opening stuff.

A Rob Horne shaped hole in the Asthma Guideline Implementation session at #BTSWinter2024. His dulcet tones waft over the Churchill Auditorium, still.

Karl Staples faces everyone’s nightmare scenario on stage - “Ah, this is the wrong slide set”. Battling on @BTSWinter2024

Glasgow’s Kevin Blythe. Meso-master. #btswinter2024

Never in doubt, Emma Johnson - You’re DundeeResp forever, now.

Lots of rubbish written about the control of breathing during exercise / use of breathing patterns / nasal breathing patterns - typically citing poor / irrelevant references. If you want a decent primer on breathing and exercise - read this: sciencedirect.com/science/articl…

🫁Respiratory researchers contributed to improved diagnostic guidelines for identifying and managing asthma, announced by NICE. The new guideline recommends chronic asthma should be diagnosed when people first show symptoms by using simple tests. 🔗manchesterbrc.nihr.ac.uk/news-and-event…